At a glance
- Originator Novartis
- Class Antivirals; Stilbenes
- Mechanism of Action Human immunodeficiency virus tat gene product inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 07 Aug 2000 New profile
- 07 Aug 2000 Preclinical development for HIV infections treatment in Switzerland (Unknown route)